Cupertino, CA, November 30, 2020.
Pharma Tech Outlook recognizes iNDX.Ai on its annual list of Top 10 Analytics Solution Providers – 2020. iNDX.Ai develops innovative software application suites combining the innovations in life sciences with the innovations in data sciences and computational logic to help scientists, researchers, and clinicians find a cure for cancer. iNDX.Ai offers a SaaS-based model that provides deeper insights to accelerate scientific discovery and cancer trials using multiomics data analytics. The list of Top 10 Analytics Solution Providers included 81qd, Golden Helix, Innoplexus, Isoplexis, Quartesian, Siren, StayinFront, Tableau, and Domino
Full details on Pharma Tech Outlook annual list of Top 10 Analytics Solution Providers – 2020 can be found at https://analytics-solution.pharmatechoutlook.com/vendors/top-analytics-solution-companies.html
“We’re honored by this industry recognition and are proud of our platform combining the innovations in life sciences with the innovations in data sciences and computational logic that will help translational and clinical researchers in finding the right medicine for the right patient at the right time.” said Mohan Uttarwar, Founder and CEO of iNDX.Ai.
“iNDX.Ai’s platform is truly an industry-leading multi-omics data processing, harmonization, and AI analytics solution for biopharmaceutical companies to gain a comprehensive insight of drug target discovery, advanced biomarker identification, and patient stratification, as they strive to deliver more effective treatments and better patient outcomes.” said Richard Friedberg, MD, PhD, Past-President, College of American Pathologists.
iNDX.Ai is a Silicon Valley based Bio-IT company that has developed iCore – an innovative informatics application suite that delivers novel insights and accelerates drug development process for precision medicine.
21580 Stevens Creek Blvd, #204, Cupertino, CA 95014, USA
P: +1 408-548-0405